These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37931230)

  • 1. Jumbo phages are active against extensively drug-resistant eyedrop-associated
    Cobián Güemes AG; Ghatbale P; Blanc AN; Morgan CJ; Garcia A; Leonard J; Huang L; Kovalick G; Proost M; Chiu M; Kuo P; Oh J; Karthikeyan S; Knight R; Pogliano J; Schooley RT; Pride DT
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0065423. PubMed ID: 37931230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of broad-spectrum phiKZ like jumbo phage and its utilisation in controlling multidrug-resistant Pseudomonas aeruginosa isolates.
    Rai P; Shetty SS; Prabell S; Kuntar A; Pinto D; Kumar BK; Divyashree M; Raj JRM; Premanath R; Deekshit VK; Karunasagar I; Karunasagar I
    Microb Pathog; 2022 Nov; 172():105767. PubMed ID: 36096457
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Alipour-Khezri E; Skurnik M; Zarrini G
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the Inhibitory Effect of Phages against
    Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing bacteriophage treatment of resistant
    Ulrich L; Steiner LX; Giez C; Lachnit T
    mSphere; 2024 Jul; 9(7):e0070723. PubMed ID: 38934592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
    Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
    Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa.
    Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M
    Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new
    Whiteley LE; Whiteley M
    Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of defense systems in phage-resistant strains of
    Costa AR; van den Berg DF; Esser JQ; Muralidharan A; van den Bossche H; Bonilla BE; van der Steen BA; Haagsma AC; Fluit AC; Nobrega FL; Haas PJ; Brouns SJJ
    Sci Adv; 2024 Feb; 10(8):eadj0341. PubMed ID: 38394193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Innate Immune Susceptibility in Hyperpigmented Bacteriophage-Resistant Mutants of Pseudomonas aeruginosa.
    Menon ND; Penziner S; Montaño ET; Zurich R; Pride DT; Nair BG; Kumar GB; Nizet V
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0023922. PubMed ID: 35862755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination.
    Ferran AA; Lacroix MZ; Gourbeyre O; Huesca A; Gaborieau B; Debarbieux L; Bousquet-Mélou A
    Microbiol Spectr; 2022 Oct; 10(5):e0287422. PubMed ID: 36135376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic biology approach to assemble and reboot clinically relevant
    Ipoutcha T; Racharaks R; Huttelmaier S; Wilson CJ; Ozer EA; Hartmann EM
    Microbiol Spectr; 2024 Mar; 12(3):e0289723. PubMed ID: 38294230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
    Montero MM; Domene-Ochoa S; López-Causapé C; López-Montesinos I; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Ferrer Alapont L; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2022 Jun; 10(3):e0089222. PubMed ID: 35695526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pseudomonas aeruginosa generalized transducing phage phiPA3 is a new member of the phiKZ-like group of 'jumbo' phages, and infects model laboratory strains and clinical isolates from cystic fibrosis patients.
    Monson R; Foulds I; Foweraker J; Welch M; Salmond GPC
    Microbiology (Reading); 2011 Mar; 157(Pt 3):859-867. PubMed ID: 21163841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety evaluation of intravenously administered
    Wang S-y; Tan X; Liu Z-q; Ma H; Liu T-b; Yang Y-q; Ying Y; Gao R-y; Zhang D-z; Ma Y-f; Chen K; Lin L; Jiang Z-h; Yu J-l
    Microbiol Spectr; 2024 Jan; 12(1):e0188223. PubMed ID: 38014983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.